Ely Benaim - 27 May 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Medical Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim
Issuer symbol
NVCR
Transactions as of
27 May 2021
Net transactions value
-$279,423
Form type
4
Filing time
28 May 2021, 16:36:12 UTC
Previous filing
14 May 2021
Next filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $87,177 +1,833 +6.3% $47.56 30,887 27 May 2021 Direct
transaction NVCR Ordinary Shares Sale $366,600 -1,833 -5.9% $200.00* 29,054 27 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1,833 -20% $0.000000 7,332 27 May 2021 Ordinary Shares 1,833 $47.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
F2 Fully vested as of the date hereof.